SCHEMBL4442911

SCHEMBL4442911

O=C(O)N(CO)C1CCCCCC1

nearest known ligand 0.46

Predicted protein targets (top 3)

geneUniProtsupporting neighboursconfidence
AGER Q15109 3/20 0.41
MTNR1A P48039 1/20 0.41
L3MBTL1 Q9Y468 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL16653682 1.00 AGER (0.41) AGERMTNR1AL3MBTL1
SCHEMBL9104933 0.98 AGER (0.38) AGERMTNR1A
SCHEMBL28521049 0.95 DPP4 (0.36)
SCHEMBL2420385 0.88
SCHEMBL11288200 0.84 AGER (0.41) AGERMTNR1AL3MBTL1
SCHEMBL1062922 0.83 AGER (0.39) AGERMTNR1AL3MBTL1
SCHEMBL967635 0.80 L3MBTL1 (0.54) L3MBTL1
SCHEMBL3892850 0.80 AGER (0.40) AGERMTNR1AL3MBTL1
SCHEMBL12987147 0.80 AGER (0.43) AGERMTNR1AL3MBTL1
SCHEMBL16333535 0.80 AGER (0.40) AGERMTNR1AL3MBTL1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2120965-A1 N-HALOGENATED AMINO COMPOUNDS AND DERIVATIVES Novabay Pharmaceuticals, Inc. (US) 2009-11-25 EP disclosed
WO-2008083347-A1 N-HALOGENATED AMINO COMPOUNDS AND DERIVATIVES NOVABAY PHARMACEUTICALS, INC. (US) 2008-07-10 WO disclosed